BOTANICAL COMBINATION OF CURCUMIN AND COPTIS CHINESE FOR THE TREATMENT OF POST-DIVERTICULITS SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE: RESULTS OF A PHASE 1B STUDY

被引：0
|
作者：
Lahat, Adi
Salomon, Nir
Neuman, Sandra
Dvir, Revital
Farkash, Hadar
Kopylov, Uri
Ben-Horin, Shomron
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1350
引用
收藏
页码：S1035 / S1035
页数：1
相关论文
共 50 条
  • [31] Initial Results of the Phase 2 Treatment-Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in Chronic Lymphocytic Leukemia
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (01) : 11 - 12
  • [32] Phase 1b/2 study of the liposomal formulation of eribulin (E7389-LF) in combination with nivolumab: Results from the phase 2 esophageal cancer cohort
    Takashi Oshima
    Sachiko Yamamoto
    Hisato Kawakami
    Tomoki Makino
    Akihito Kawazoe
    Toshiki Masuishi
    Takahiro Tsushima
    Motohiro Hirao
    Masahiro Tsuda
    Kaori Hino
    Noboru Yamamoto
    Hiroki Hara
    Shota Kaname
    Daiko Matsuoka
    Yohei Otake
    Keisuke Yasuda
    Takao Takase
    Shuya Takashima
    Taro Semba
    Akira Ooki
    BJC Reports, 2 (1):
  • [33] A phase 1b study of crizotinib in combination with temsirolimus in pediatric ALK- or MET-aberrated relapsed or refractory neuroblastoma (ITCC-053): Results of the phase 1 part
    Schellekens, Kim
    Schoot, Reineke Anna
    van Eijkelenburg, Natasha K. A.
    Huitema, Alwin
    Casanova, Michela
    Reinhardt, Dirk
    Marshall, Lynley V.
    Aerts, Isabelle
    Barone, Giuseppe
    Chesler, Louis
    Tall, Jennifer
    Hughes, Debbie
    Dandis, Rana
    Moreno, Lucas
    Winkler-Seinstra, Pauline L. H.
    Wilner, Keith D.
    Zwaan, C. Michel
    van der Lugt, Jasper
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [34] Updated Results of a Phase 1b/2 Study of Ibrutinib in Chronic Graft Versus Host Disease After Failure of Prior Therapy
    Waller, Edmund K.
    Miklos, David
    Cutler, Corey S.
    Arora, Mukta
    Jagasia, Madan
    Pusic, Iskra
    Flowers, Mary E.
    Logan, Aaron C.
    Nakamura, Ryotaro
    Dubovsky, Jason
    Chang, Stephen
    Clow, Fong
    Lal, Indu D.
    Styles, Lori
    Jaglowski, Samantha
    BONE MARROW TRANSPLANTATION, 2018, 53 : 71 - 73
  • [35] TITLE: PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD): PRELIMINARY RESULTS.
    Pina, Yolanda
    Chen, Ann
    Arrington, John A.
    Macaulay, Rob
    Tran, Nam
    Liu, James
    Mokhtari, Sepideh
    Li, Jiannong
    Law, Vincent
    Sahebjam, Solmaz
    Ahmed, Kamran
    Creelan, Ben
    Gray, Jhanelle
    Wallace, Gerald
    Evernden, Brittany
    Stewart, Christine L.
    Khushalani, Nikhil
    Smalley, Inna
    Smalley, Keiran
    Vogelbaum, Michael
    Yu, Michael
    Forsyth, Peter
    NEURO-ONCOLOGY, 2022, 24 : 59 - 59
  • [36] Initial results from a phase 1b study of ORIC-101, a glucocorticoid receptor antagonist, in combination with enzalutamide in patients with metastatic prostate cancer
    Abida, Wassim
    Agarwal, Neeraj
    Hahn, Andrew W.
    Shore, Neal
    Sieber, Paul
    Dorff, Tanya
    Rettig, Mathew
    Smith, Mathew
    Monk, Paul
    Xu, Rongda
    Johnson, Ann
    Daemen, Anneleen
    Maneval, Edna Chow
    Multani, Pratik S.
    Patel, Rupal
    Morris, Michael J.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [37] Phase 1b study of motesanib diphosphate (AMG 706) in combination with paclitaxel or docetaxel for the treatment of locally recurrent, unresectable or metastatic breast cancer
    Kaufman, P. A.
    de Boer, R.
    White, S.
    Mainwaring, P.
    Koczwara, B.
    Drury, S.
    Ye, Y.
    Sun, Y-N
    Sikorski, R.
    Kotasek, D.
    CANCER RESEARCH, 2009, 69 (02) : 285S - 286S
  • [38] Pharmacokinetics and safety of elotuzumab in combination with lenalidomide and dexamethasone in patients with multiple myeloma and various levels of renal function: updated results of a phase 1b study
    Paliwal, P.
    Berdeja, J.
    Jagannath, S.
    Zonder, J.
    Badros, A.
    Kaufman, J. L.
    Manges, R.
    Lynch, M.
    Bleickardt, E.
    Vij, R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 69 - 70
  • [39] Magrolimab in Combination With Azacitidine for Patients With Untreated Higher-Risk Myelodysplastic Syndromes: 5F9005 Phase 1b Study Results
    Sallman, David A.
    Al Malki, Monzr M.
    Asch, Adam S.
    Wang, Eunice S.
    Jurcic, Joseph G.
    Bradley, Terrence J.
    Flinn, Ian W.
    Pollyea, Daniel A.
    Kambhampati, Suman N.
    Tanaka, Tiffany N.
    Zeidner, Joshua F.
    Garcia-Manero, Guillermo
    Jeyakumar, Deepa
    Gu, Lin
    Tan, Anderson
    Chao, Mark
    O'Hear, Carol
    Lal, Indu
    Vyas, Paresh
    Daver, Navel
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S20 - S21
  • [40] Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 Trial
    Kudo, Masatoshi
    Motomura, Kenta
    Wada, Yoshiyuki
    Inaba, Yoshitaka
    Sakamoto, Yasunari
    Kurosaki, Masayuki
    Umeyama, Yoshiko
    Kamei, Yoichi
    Yoshimitsu, Junichiro
    Fujii, Yosuke
    Aizawa, Mana
    Robbins, Paul B.
    Furuse, Junji
    LIVER CANCER, 2021, 10 (03) : 249 - 259
12345